Design and evaluation in vitro of controlled release mucoadhesive tablets containing chlorhexidine.
This investigation deals with the development of buccal tablets containing chlorhexidine (CHX), a bis-bis-guanide with antimicrobial and antiseptic effects in the oral cavity, and able to adhere to the buccal mucosa to give local controlled release of drug. A mucoadhesive formulation was designed to swell and form a gel adhering to the mucosa and controlling the drug release into the oral cavity. Some batches of tablets were developed by direct compression, containing different amounts of hydroxypropylmethylcellulose (HPMC) and carbomer; changing the amount ratio of these excipients in formulations, it is possible easily modulate the mucoadhesive effect and release of drug. The in vitro tests were performed using the USP 26/NF paddle apparatus, a specifically developed apparatus, and a modified Franz diffusion cells apparatus. This last method allows a simultaneous study of drug release rate from the tablets and drug permeation through the buccal mucosa. Similar tests have also been carried out on a commercial product, Corsodyl gel, in order to compare the drug release control of gel with respect to that of the mucoadhesive tablet, as a formulation for buccal delivery of CHX. While the commercial formulation does not appear to control the release, the formulation containing 15% w/w methocel behaves the best, ensuring the most rapid and complete release of the drug, together with a negligible absorption of the active agent as required for a local antiseptic action in the oral cavity.
Carlo Ceschel
Gian
G
Department of Pharmaceutical Sciences, University of Bologna, Bologna, Italy. ceschel@biocfarm.unibo.it
Bergamante
Valentina
V
Calabrese
Valeria
V
Biserni
Stefano
S
Ronchi
Celestino
C
Fini
A
A
D000268:Adhesiveness; D002710:Chlorhexidine / Q000008:administration & dosage* / Q000737:chemistry; D003692:Delayed-Action Preparations; D009061:Mouth Mucosa / Q000378:metabolism*; D010539:Permeability; D012995:Solubility; D013607:Tablets; D013678:Technology, Pharmaceutical
D003692:Delayed-Action Preparations; D013607:Tablets; D002710:Chlorhexidine